UBS Group’s Nuveen Corporate Income 2023 Target Term Fund JHAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100
| Closed | -$954 | – | 10405 |
|
|
2023
Q3 | $954 | Sell |
100
-1,746
| -95% | -$16.5K | ﹤0.01% | 8207 |
|
|
2023
Q2 | $17.3K | Buy |
1,846
+1,775
| +2,500% | +$16.5K | ﹤0.01% | 6940 |
|
|
2023
Q1 | $652 | Sell |
71
-2,026
| -97% | -$18.6K | ﹤0.01% | 8939 |
|
|
2022
Q4 | $19K | Sell |
2,097
-2,264
| -52% | -$20.5K | ﹤0.01% | 7702 |
|
|
2022
Q3 | $39K | Buy |
4,361
+3,353
| +333% | +$30.5K | ﹤0.01% | 6597 |
|
|
2022
Q2 | $9K | Sell |
1,008
-124
| -11% | -$1.15K | ﹤0.01% | 8212 |
|
|
2022
Q1 | $11K | Sell |
1,132
-1,247
| -52% | -$12.1K | ﹤0.01% | 8344 |
|
|
2021
Q4 | $24K | Buy |
2,379
+998
| +72% | +$9.94K | ﹤0.01% | 7653 |
|
|
2021
Q3 | $14K | Sell |
1,381
-802
| -37% | -$7.98K | ﹤0.01% | 7614 |
|
|
2021
Q2 | $22K | Buy |
2,183
+167
| +8% | +$1.67K | ﹤0.01% | 7245 |
|
|
2021
Q1 | $20K | Sell |
2,016
-1,055
| -34% | -$10.5K | ﹤0.01% | 7402 |
|
|
2020
Q4 | $29K | Buy |
+3,071
| New | +$29.3K | ﹤0.01% | 6670 |
|
|
2020
Q1 | – | Sell |
-339
| Closed | -$4K | – | 8550 |
|
|
2019
Q4 | $4K | Buy |
+339
| New | +$3.6K | ﹤0.01% | 7694 |
|
|
2019
Q3 | – | Sell |
-7,533
| Closed | -$77K | – | 8354 |
|
|
2019
Q2 | $77K | Buy |
7,533
+6,167
| +451% | +$62.6K | ﹤0.01% | 5579 |
|
|
2019
Q1 | $14K | Buy |
1,366
+426
| +45% | +$4.4K | ﹤0.01% | 6608 |
|
|
2018
Q4 | $10K | Buy |
+940
| New | +$9.74K | ﹤0.01% | 7250 |
|
UBS Group's JHAA Position: Q4 2023 in Review
UBS Group sold out of Nuveen Corporate Income 2023 Target Term Fund (JHAA) in Q4 2023, closing a stake of 100 shares — an estimated $954 sold.
UBS Group first reported a position in JHAA in Q4 2018 and held it in 16 quarters. The position peaked at $77K in Q2 2019. 0 funds tracked by Wall St. Rank hold JHAA as of Q4 2023.
- UBS Group reported no remaining Nuveen Corporate Income 2023 Target Term Fund position as of Q4 2023 after selling out during the quarter.
- UBS Group sold 100 Nuveen Corporate Income 2023 Target Term Fund shares in Q4 2023, an estimated $954.
- UBS Group first reported a position in Nuveen Corporate Income 2023 Target Term Fund in Q4 2018 and held it in 16 quarters.
- UBS Group's Nuveen Corporate Income 2023 Target Term Fund position peaked at $77K in Q2 2019.
- 0 funds tracked by Wall St. Rank held Nuveen Corporate Income 2023 Target Term Fund as of Q4 2023.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.